Navigation Links
ALS Therapy Development Institute and Anida Pharma Partner to Investigate Potential Treatments for ALS
Date:9/10/2013

e philanthropy investments in small biotechs like Anida Pharma. Previous venture philanthropy investments have been made with to-BBB, Neurotune, Regenesance, Glialogix, Aestus and others under confidential agreements.

"The possibility to partner with ALS TDI as a world-leading institute for ALS research is an extraordinary opportunity for Anida to accelerate its ALS drug development program towards the clinic. We believe that based on its unique property of multiple actions: regulating inflammation and cell death, but also exerting neurotrophic effects, NPD1 offers an exciting potential for the treatment of ALS," says Per Gjorstrup, M.D., Ph.D., President and CEO of Anida Pharma. 

About ALS
Amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) is a progressive neurodegenerative disease that leads to paralysis, due to the death of motor neurons in the spinal cord and brain. There is no known cure for the disease. About 5,000 people in the US are diagnosed with ALS each year; the incidence is similar to multiple sclerosis. However, with no effective treatment, the average patient survives only two to five years following diagnosis. There are about 30,000 people in the US diagnosed with ALS today. The worldwide population of ALS patients is estimated at 450,000.

About ALS Therapy Development Institute (ALS TDI)
The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) as soon as possible for patients today. Focused on meeting this urgent unmet medical need, ALS TDI executes a robust target discovery program, while simultaneously operating the world's largest efforts to preclinically determine the efficacy of potential th
'/>"/>

SOURCE ALS Therapy Development Institute
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
3. IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
6. Aperture Health, Inc. focuses in on IV Therapy Value Creation and the Merger and Acquisition Activities in the Home Infusion Therapy Sector.
7. BHI Raises Awareness of Hearing Aids as Potential Therapy to Help Quiet "Ringing in the Ears" During National Tinnitus Awareness Week
8. Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
9. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
10. Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy
11. The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... CHAPEL HILL, N.C. , July 2, 2015 ... their own employees to capture critical product and ... there are many benefits to employee-based studies, it ... to leverage their own internal employees to capture ... recent study by benchmarking firm, Best Practices, LLC, ...
(Date:7/2/2015)... 2, 2015  Fort Lauderdale-based investment banking firm, ... that its Consumer Group completed the sale of ... plc (ISE: KRZ) ("Kerry"), one of the leading ... as well as functional ingredients and actives for ... Turner served as the exclusive financial advisor to ...
(Date:7/2/2015)... According to a new market research report " ... Stimulation, Transcranial Magnetic Stimulation), Application (Depression, Parkinson,s, Tinnitus, Alzheimer,s, Epilepsy, ... MarketsandMarkets, the global Neuromodulation Market is estimated at $3.65 Billion ... 2020, at a CAGR of 11.2% during the forecast period. ... market data T ables and 32 ...
Breaking Medicine Technology:Leveraging Employee Insights to Produce Cutting-Edge Market Research 2Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4
... 11, 2011 The U.S. Food and Drug Administration ... help manage potential organ rejection in kidney transplant patients. ... level of everolimus, a drug that helps prevent rejection ... ) Everolimus, marketed under the trade ...
... U.S. Food and Drug Administration today approved the Selenia ... three-dimensional (3-D) images of the breast for breast cancer ... A mammogram is a safe, low-dose ... for early detection of breast cancer. However, with the ...
Cached Medicine Technology:FDA Clears Test to Help Patients With Kidney Transplants 2FDA Approves First 3-D Mammography Imaging System 2
(Date:7/3/2015)... Red Deer, Alberta (PRWEB) , ... July 03, 2015 , ... ... Camp host their 24-Hour Train-a-Thon where they provide members of the Red Deer community ... This year’s full day of fitness training, games, food, events and entertainment raised thousands ...
(Date:7/2/2015)... ... ... Following the recent report by JAMA Internal Medicine published on ... Samir Becic emphatically declared a war on obesity in the United States. , "Obesity ... must understand the magnitude of this discovery. For that reason, I am declaring, along ...
(Date:7/2/2015)... ... , ... In 2012, Patrick Achebe realized that the gift of poetry was fully in him, ... his first poem, and three years later he was publishing an entire book of poetry. ... the world. "I have always believed that the best way to lift yourself up, is ...
(Date:7/2/2015)... ... ... Six months ahead of his 80th birthday, Don Stevenson has reached the ... the Pulmonary Hypertension Association (PHA). Stevenson began the walk in Washington State three ... He left Glasgow, Mont. yesterday morning and is making his way to Wolf Point. ...
(Date:7/2/2015)... CA (PRWEB) , ... July 02, 2015 , ... ... of Dr. Divakar R. Krishnareddy, M.D., to the orthopedic and spine surgery team ... disc herniations, sprains, strains, bursitis, and tendonitis. Along with the spine and spine ...
Breaking Medicine News(10 mins):Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3
... that fetal cell transplantation for patients with Parkinson’s ... their medications altogether.// ,Parkinson’s disease is ... with Parkinson’s lack the chemical dopamine, which is ... aborted human fetal tissue to replace the lost ...
... groggy and restless every morning. What many don't know is that ... be what's keeping them awake. Sleep specialists say as we age, ... but they also say its never too late to get back ... to do is to cut out caffeine after noon and to ...
... of a recent study researchers say annual flu vaccines in ... hospitalizations, respiratory tract infections, and other key measures. ,The ... form of the flu virus in their shots. Children who ... be somewhat more protected. However, for children under age 2 ...
... 140th Midwinter Meeting that begins in US today, it ... take a peek to some very innovative and original ... The convention is also one of the largest exhibitions ... showcase of products from 46 countries will include flavored ...
... examining 1,116 sets of twins and their mothers to see ... children's first five years // of life and children's antisocial ... mothers were found to have increased problems with conduct and ... showed maternal depression after the twins' birth and the likeliness ...
... Southern California School of Dentistry has devised a test to ... saliva// to measure the relative concentration of various sugar chains ... same as those present in the teeth surface. Some sugar ... certain bacteria to bond with the tooth. Each individual sugar ...
Cached Medicine News:
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: